Opportunity ID: 299047

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-214
Funding Opportunity Title: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.173 — Research Related to Deafness and Communication Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 28, 2017
Last Updated Date: Jan 17, 2020
Original Closing Date for Applications: Apr 03, 2020
Current Closing Date for Applications: Aug 07, 2020
Archive Date: Sep 06, 2020
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: State governments
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
City or township governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Independent school districts
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-214.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
updated close date as per the notice NOT-HD-20-002 Jan 17, 2020
Nov 28, 2017

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-214
Funding Opportunity Title: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.173 — Research Related to Deafness and Communication Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Nov 28, 2017
Last Updated Date: Jan 17, 2020
Original Closing Date for Applications: Apr 03, 2020
Current Closing Date for Applications: Aug 07, 2020
Archive Date: Sep 06, 2020
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: State governments
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
City or township governments
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Independent school districts
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-214.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-214
Funding Opportunity Title: Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.173 — Research Related to Deafness and Communication Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 28, 2017
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 03, 2020
Archive Date: May 09, 2020
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
For profit organizations other than small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
State governments
Public and State controlled institutions of higher education
Private institutions of higher education
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-214.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00236605 Mar 05, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00260039 Mar 05, 2018 Aug 07, 2020 View

Package 1

Mandatory forms

299047 RR_SF424_2_0-2.0.pdf

299047 PHS398_CoverPageSupplement_4_0-4.0.pdf

299047 RR_OtherProjectInfo_1_4-1.4.pdf

299047 PerformanceSite_2_0-2.0.pdf

299047 RR_KeyPersonExpanded_2_0-2.0.pdf

299047 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

299047 RR_Budget_1_4-1.4.pdf

299047 RR_SubawardBudget30_1_4-1.4.pdf

299047 PHS398_ModularBudget_1_2-1.2.pdf

299047 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

299047 RR_SF424_2_0-2.0.pdf

299047 PHS398_CoverPageSupplement_5_0-5.0.pdf

299047 RR_OtherProjectInfo_1_4-1.4.pdf

299047 PerformanceSite_2_0-2.0.pdf

299047 RR_KeyPersonExpanded_2_0-2.0.pdf

299047 PHS398_ResearchPlan_4_0-4.0.pdf

299047 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

299047 RR_Budget_1_4-1.4.pdf

299047 RR_SubawardBudget30_1_4-1.4.pdf

299047 PHS398_ModularBudget_1_2-1.2.pdf

299047 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T21:05:20-05:00

Share This Post, Choose Your Platform!

About the Author: